Description

The Hepatic Fibrosis Test YRA317 // YRA321 is an essential diagnostic tool for early detection of liver fibrosis. This product allows for the identification of liver fibrosis at an early stage, improving patient prognosis by enabling timely intervention to reverse or delay progression. It is compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, making it a versatile choice for modern laboratories.

Market Price

In the competitive market of diagnostic tests, the Hepatic Fibrosis Test YRA317 // YRA321 is offered at a mid to premium price range. Prices can vary based on factors such as distribution channels and regional demand, but generally, customers can expect a price range from $200 to $400 per kit, depending on the supplier and additional services provided.

Frequently Asked Questions

What is the primary use of the Hepatic Fibrosis Test? This test is primarily used for detecting and monitoring liver fibrosis, crucial for preventing further development into cirrhosis.

How compatible is this test with existing laboratory equipment? The test is highly compatible, designed for seamless integration with Chemiluminescence Immunoassay Analyzers like the YR06389 and YR06390 models.

What is the packaging form of the test? The test is available in packages of 50T/BOX, ensuring sufficient quantity for regular laboratory workflows.

Advantages and Disadvantages

The key advantage of the Hepatic Fibrosis Test YRA317 // YRA321 is its early detection capability, which can greatly enhance patient outcomes. Additionally, its compatibility with existing analyzers means labs can integrate it without significant new investment. However, some users might consider the initial cost to be a potential drawback, especially small-scale operations, though the long-term benefits often justify the investment.

Field Usage

In practical settings, the Hepatic Fibrosis Test YRA317 // YRA321 is used routinely in hospitals and specialized clinics. Laboratories employing this test appreciate its reliability and the rapid turnaround of results, which facilitates timely clinical decision-making. It supports medical professionals in crafting personalized treatment plans for patients with liver conditions.

Recommendations

To maximize the benefits of the Hepatic Fibrosis Test YRA317 // YRA321, laboratories should ensure proper storage conditions. Maintaining temperatures between 2-8°C is essential for test integrity. Regular calibration using the provided calibration points is recommended to sustain accuracy. For institutions interested in acquiring this diagnostic powerhouse, we encourage requesting a quote or generating an automatic quotation through the Kalstein Plus platform today.

Features

• Early detection of liver fibrosis.
• Compatible with YR06389 and YR06390 Chemiluminescence Immunoassay Analyzers.
• Robust packaging with 50T per box.
• Certifications include CE, ISO13485, and FSC.

Technical Specifications